Cy-Car-D

Right now, I’m getting cyclophosphamide (Cytoxan), carfilzomib (Kyprolis), and dexamethasone every week.  I’m tolerating it very well.   Even though I had it in 2019 and eventually relapsed, it’s working for me. After this, I’m hoping to try TAK-573 in a clinical trial. Abstract Background TAK-573, a humanized, anti-CD38, IgG4, monoclonal antibody genetically fused to two …
Source: beth's myeloma blog - Category: Cancer & Oncology Authors: Tags: carfilzomib cyclophosphamide dexamethasone TAK-573 Source Type: blogs